Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)

Medigene AG / Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Details of the person subject to the disclosure requirement Name: Mathias,  Frank Professional role: Person with executive functions:   Member of a managing body Details of the relationship: CEO     Designation of the financial instrument ISIN: DE000A11QVD8 Designation: Medigene AG NA O.N.JGE     Details of the transaction Type of transaction: Purchase Date: 22.07.2014 Place (stock exchange): Frankfurt Price: 5.00 Currency: EUR Quantity: 428 Business volume: 2140     Details of the company with the publishing obligation: Issuer: Medigene AG Lochhamer Strasse 11 D-82152   Martinsried / München Germany ISIN: DE000A1X3W00 WKN: A1X3W0

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medigene AG via Globenewswire
HUG#1840592

--- End of Message ---

Medigene AG
Lochhamer Strasse 11 Martinsried / München Germany

WKN: A1X3W0;ISIN: DE000A1X3W00;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;